PHENOTHIAZINE

Course overview

PHENOTHIAZINES ARE TERMED FIRST-GENERATION HETEROCYCLIC ANTI-PSYCHOTIC MEDICATIONS WHICH DISPLAY ANTAGONISTIC ACTIVITY TOWARDS DOPAMINE RECEPTORS AS WELL AS RECENTLY HAVE SHOWCASED POTENTIAL ANTI-NEOPLASTIC PROPERTIES. THIS ACTIVITY ILLUSTRATES THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR PHENOTHIAZINE AS A VALUABLE AGENT IN THE TREATMENT AND MANAGEMENT OF SEVERE MENTAL DISORDERS SUCH AS SCHIZOPHRENIA, CANCER, OTHER MANIFESTATIONS OF PSYCHOSIS. ALSO, THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS SUCH AS PHARMACODYNAMICS AND RELEVANT INTERACTIONS PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL HEALTHCARE TEAM CHARGED WITH THE CARE OF PATIENTS WITH SCHIZOPHRENIA AND OTHER RELATED CONDITIONS.